Japanese drug companies modifies their strategy in market entry.

Published: 1999-11-01 14:41:00

Updated: 1999-11-01 14:41:00

After the IMF economic crisis many foreign multinational pharmaceutical corporations were emerged out of the depressed business environment with more aggressive market entry by means of taking over the shares owned by their Korean business counter partners for their whole management controls.

...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK